13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
SCHEDULE Filed 2025-02-10 Event 2025-02-06 SEC 0001753926-25-000200 →

Chancellor Michael B LIPELLA PHARMACEUTICALS INC. LIPO

Stake: 7.90% Shares: 209,640 CUSIP: 53630L209 Class: Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

The information contained in rows 7, 8, 9, 10, 11 and 13 of the cover page of this Amendment No. 8 and the corresponding comment, and the information set forth in or incorporated by reference into Item 2, Item 3, Item 5, Item 6 and Item 7 of this Amendment No. 8 is hereby incorporated by reference in its entirety into this Item 4. Except as described in this Item 4 above, the information contained in "Item 4. Purpose of Transaction." of the Schedule 13D is not being amended by this Amendment No. 8.

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
6 13D/G filings on this issuer
5 other filings besides this one
Filer Track Record
2 filings by this filer
1 other filing in the data moat
Short Interest · settle 2026-03-31
DTC 1.00
2,579 shares short · +0.0% vs prior

Other 13D/G Filings on LIPELLA PHARMACEUTICALS INC.

FiledFormFilerStakeShares
2025-03-17 SCHEDULE Kaufman Jonathan H 8.00% 212,289 view →
2025-03-03 SCHEDULE Kaufman Jonathan H 8.00% 212,289 view →
2025-02-10 SCHEDULE Kaufman Jonathan H 8.00% 212,289 view →
2025-01-23 SCHEDULE Kaufman Jonathan H 11.70% 212,289 view →
2025-01-23 SCHEDULE Chancellor Michael B 11.50% 209,640 view →

Other Filings by Chancellor Michael B

FiledFormIssuerStakeShares
2025-01-23 SCHEDULE LIPELLA PHARMACEUTICALS INC. LIPO 11.50% 209,640 view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →